MPM BIOIMPACT LLC: 13F holdings
CIK 16870782026Q2
| Positions | 37 |
|---|
| Reported value | $1.6bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 37 (-4 vs prior quarter) |
|---|
| Reported value | $1.6bn (+26.6%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| CGEM Cullinan Therapeutics, Inc. | 9,731,341 | $177.2m | 10.8% |
| Aktis Oncology, Inc. | 4,835,872 | $155.9m | 9.5% |
| LQDA Liquidia Corporation | 1,386,174 | $110.5m | 6.7% |
| RVMD Revolution Medicines, Inc. | 492,483 | $92.2m | 5.6% |
| CORT Corcept Therapeutics, Inc. | 771,028 | $67.0m | 4.1% |
| EWTX Edgewise Therapeutics Inc | 1,620,780 | $65.9m | 4.0% |
| TVTX Travere Therapeutics Inc | 1,122,731 | $63.8m | 3.9% |
| DBV Technologies S A | 3,666,284 | $60.1m | 3.7% |
| TRVI Trevi Therapeutics Inc | 3,073,577 | $57.3m | 3.5% |
| ALMS Alumis Inc | 2,019,020 | $56.8m | 3.5% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1687078")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples